A cellular osmotic pressure sensor
细胞渗透压传感器
基本信息
- 批准号:10153828
- 负责人:
- 金额:$ 23.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAreaAutomobile DrivingBehaviorBindingBinding SitesBiochemicalBiologicalBiomedical ResearchCell VolumesCell WallCell membraneCell modelCellsCommunitiesCrowdingDNADNA BindingDNA SequenceDataDependenceDevelopmentDiffuseElementsEnhancersEnvironmentEquipmentExposure toFutureGasesGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionHydration statusImageImpairmentIn SituInvestigationKnowledgeLaboratoriesLaboratory ResearchLifeMeasurableMeasurementMeasuresMechanical StressMechanicsMembraneMetabolicModelingMolecularOrganismOsmolalitiesOsmoregulationOsmotic PressurePermeabilityPhysical shapePhysiologicalPlantsProcessProkaryotic CellsProliferatingPropertyProteinsPublishingReagentRecoveryRegulationReporterReporter GenesReportingResearchResearch PersonnelRisk ManagementStressSwellingSystemTechnologyTestingTimeTransactivationTranslatingVariantVesicleWaterWater MovementsYeastsbasebiological adaptation to stresscell typecofactorcostdesignenvironmental stressorexperimental studyhuman diseasein vivoinnovationinsightinstrumentationinterestminiaturizemutantnovelnovel strategiespressure sensorpromoterratiometricresponsesensorsolutetooltranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
Fluctuations in osmotic pressure represent a critical challenge of the cellular environment. Differences in solution
composition across plasma membranes cause bulk water movement in the direction of decreasing water activity,
driving cell shrinkage or swelling. Cells dynamically respond to such stresses with osmo-regulatory mechanisms
aimed at maintaining volume (tonic) control. Depending on the cell’s tolerance for mechanical stress, the adapted
state may only partially correct the underlying osmotic imbalance. As a result, variations in intracellular water
activity also perturb osmotically sensitive interactions that involve changes in molecular hydration. Osmotic
stress arises from exposure to non-isotonic environments or rapid metabolic turnover in proliferating cells, and
an increasing number of human diseases are connected to persistent osmotic stress. Osmotic pressure is
therefore a parameter of interest to many areas of biomedical research. Current technologies cannot directly
access osmotic pressure inside the cell. They infer osmotic pressure from functional or other correlates such as
cell volume, gas vesicles, gene expression or macromolecular crowding. These indirect metrics, which are
particular to different cell types but not specific to osmotic disturbances, limit their general utility. Direct access
to intracellular osmotic pressure would enable investigators to establish a standard metric for evaluating osmotic
responses, and compare different cellular systems or stress conditions. To address this unmet need, this
proposal is aimed at validating a novel solution to directly report intracellular osmotic pressure using common
imaging and flow cytometric instrumentation. Our approach is based on osmotically sensitive transcription
factors, which bind high- and low-affinity DNA target sequences with distinct dependence on osmotic pressure.
We postulate that differential transactivation of reporter genes by osmotically sensitive transcription factors at
high- and low-affinity DNA enhancers could yield a direct ratiometric readout of the intracellular osmotic pressure.
To validate this concept, we will use as initial design the transcription factor PU.1, whose osmotic sensitivities
are characterized. We will 1) construct fluorescent protein reporter systems that are differentially responsive to
osmotic pressure. 2) We will validate their operational basis using osmotically impaired mutant factors and
calibrate the osmotic pressure readout in live cells. 3) To maximize the addressable range of organisms, we will
generalize our design to remove the requirement for factor-specific transcriptional machinery. 4) Finally, we will
integrate a time-sensitive feature into the sensor by controlling metabolic reporter turnover. An emphasis in our
approach is a modular design that will accept a wide range of alternate transcription factors, promoters, and
reporter moieties. This feature greatly enhances risk management. If successful, these innovations will lead to a
direct and non-invasive approach for directly determining the latency, rate, and completeness of hypo- and
hyperosmotic stress response by cells from all kingdoms of life.
项目概要/摘要
渗透压的波动代表了细胞环境差异的关键挑战。
跨质膜的成分导致大量水向水活度降低的方向运动,
驱动细胞收缩或肿胀。细胞通过渗透调节机制动态地响应这种压力。
旨在维持音量(强直)控制,具体取决于细胞对机械应力的耐受性。
状态可能只能部分纠正潜在的渗透不平衡,从而导致细胞内水的变化。
活性还会扰乱涉及分子水合作用变化的渗透敏感相互作用。
压力是由于暴露于非等渗环境或增殖细胞的快速代谢更替而产生的,并且
越来越多的人类疾病与持续的渗透压有关。
因此,当前技术无法直接确定生物医学研究许多领域感兴趣的参数。
他们从功能或其他相关因素(例如)推断渗透压。
细胞体积、气泡、基因表达或大分子拥挤这些间接指标。
特定于不同的细胞类型但不特定于渗透压紊乱,限制了它们的一般用途。
细胞内渗透压将使研究人员能够建立评估渗透压的标准指标
响应,并比较不同的细胞系统或压力条件,为了解决这一未满足的需求,这
该提案旨在验证一种使用常见方法直接报告细胞内渗透压的新解决方案
我们的方法基于渗透敏感转录。
结合高亲和力和低亲和力 DNA 靶序列的因素,对渗透压有明显的依赖性。
我们假设渗透敏感转录因子对报告基因的差异反式激活
高亲和力和低亲和力 DNA 增强剂可以产生细胞内渗透压的直接比例读数。
为了验证这个概念,我们将使用转录因子 PU.1 作为初始设计,其渗透敏感性
我们将 1) 构建对不同的荧光蛋白有不同响应的荧光蛋白报告系统。
2)我们将使用渗透压受损的突变因子来验证其操作基础
校准活细胞中的渗透压读数 3) 为了最大化生物体的可寻址范围,我们将
推广我们的设计以消除对因子特异性转录机制的要求 4)最后,我们将。
通过控制代谢报告基因周转,将时间敏感功能集成到传感器中,这是我们的重点。
方法是一种模块化设计,可接受多种替代转录因子、启动子和
如果成功,这些创新将大大增强风险管理。
直接和非侵入性方法,用于直接确定低级和低级的潜伏期、速率和完整性
来自所有生命王国的细胞的高渗应激反应。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Non-continuum Nature of Eukaryotic Transcriptional Regulation.
- DOI:10.1007/5584_2021_618
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Poon GMK
- 通讯作者:Poon GMK
Dissecting Dynamic and Hydration Contributions to Sequence-Dependent DNA Minor Groove Recognition.
剖析动态和水合对序列依赖性 DNA 小沟识别的贡献。
- DOI:10.1016/j.bpj.2020.08.013
- 发表时间:2020
- 期刊:
- 影响因子:3.4
- 作者:Ha,VanLT;Erlitzki,Noa;Farahat,AbdelbassetA;Kumar,Arvind;Boykin,DavidW;Poon,GregoryMK
- 通讯作者:Poon,GregoryMK
Dissecting Knowledge, Guessing, and Blunder in Multiple Choice Assessments
剖析多项选择评估中的知识、猜测和错误
- DOI:10.1080/08957347.2023.2172017
- 发表时间:2023
- 期刊:
- 影响因子:1.5
- 作者:Abu-Ghazalah, Rashid M.;Dubins, David N.;Poon, Gregory M.K.
- 通讯作者:Poon, Gregory M.K.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory Man Kai Poon其他文献
Gregory Man Kai Poon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory Man Kai Poon', 18)}}的其他基金
Direct chemical control of the hematopoietic master transcription factor PU.1
造血主转录因子 PU.1 的直接化学控制
- 批准号:
10540346 - 财政年份:2021
- 资助金额:
$ 23.39万 - 项目类别:
Direct chemical control of the hematopoietic master transcription factor PU.1
造血主转录因子 PU.1 的直接化学控制
- 批准号:
10322390 - 财政年份:2021
- 资助金额:
$ 23.39万 - 项目类别:
Direct activation of hematopoietic transcription factors
直接激活造血转录因子
- 批准号:
8947574 - 财政年份:2015
- 资助金额:
$ 23.39万 - 项目类别:
Osmotic responsiveness of the master immune regulator PU.1
主免疫调节剂 PU.1 的渗透反应性
- 批准号:
8770311 - 财政年份:2014
- 资助金额:
$ 23.39万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 23.39万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 23.39万 - 项目类别:
A simulation platform to predict dose and therapeutic window of immunocytokines
预测免疫细胞因子剂量和治疗窗的模拟平台
- 批准号:
10698708 - 财政年份:2023
- 资助金额:
$ 23.39万 - 项目类别: